Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C
about
Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemicMechanisms of intrahepatic triglyceride accumulationMolecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASHLiver steatosis in hepatitis C patientsEndocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease.Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease.PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.Liver X receptor α is essential for the capillarization of liver sinusoidal endothelial cells in liver injuryReview article: non-alcoholic fatty liver disease and osteoporosis--clinical and molecular crosstalk.Role of microRNAs in the regulation of drug metabolism and disposition genes in diabetes and liver disease.Osteopontin: Versatile modulator of liver diseases.Targeting liver X receptors in inflammation.Oxysterols and redox signaling in the pathogenesis of non-alcoholic fatty liver disease.Potent effects of dioscin against obesity in miceHepatitis regulation by the inflammasome signaling pathway.Molecular mechanisms of fatty liver in obesity.Comparative analysis of gene expression profiles of OPN signaling pathway in four kinds of liver diseases.Total saponins from Rosa laevigata Michx fruit attenuates hepatic steatosis induced by high-fat diet in rats.HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis.Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication.The potential of signal peptide peptidase as a therapeutic target for hepatitis C.Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice.22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXRα.Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice.Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease.Fatty acid binding profile of the liver X receptor α.Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.DNA methylation patterns of peroxisome proliferator-activated receptor gamma gene associated with liver fibrosis and inflammation in chronic hepatitis B.Melatonin treatment reduces endoplasmic reticulum stress and modulates the unfolded protein response in rabbits with lethal fulminant hepatitis of viral origin.Effect of metformin treatment on circulating osteoprotegerin in patients with nonalcoholic fatty liver disease.Structural Proteins of HCV and Biological FunctionsHypoxia-inducible factor-1 modulates the expression of vascular endothelial growth factor and endothelial nitric oxide synthase induced by eccentric exercise
P2860
Q24563381-FFAA9903-B722-48F0-894B-4B823C0834A4Q26773198-93E6BE19-FEB0-4A78-95CC-CDC8A64F7A24Q26778376-E211FB75-F04D-40BC-9971-18772D6503F1Q27010631-6E748FAE-4858-4C64-8229-D0C8FE5CBECCQ33597839-4C2DBF16-DC5F-4061-A131-C128DD852D1EQ34834198-05D34C93-B3F1-4E83-A2E6-FDE5759FBDC9Q36253614-336A1D05-EFA4-4615-B580-95393A566E9FQ36591996-94672552-63EE-4921-8709-5342FC2F606CQ38021479-BA45B822-0398-4DAB-A419-050AE3F62362Q38097092-C4B67B5F-2384-4081-8ABF-7FDD81AEF8DFQ38108842-24B81138-56DC-4874-80D0-A4A14E2255F7Q38112165-C67E429E-0872-4B30-8F27-243D414AA2A4Q38133807-F7EAC79F-23C9-4F01-BBDF-87B5F178E7DDQ38301574-5FA403FB-C6E6-4EB3-8F2E-FFA7C1B8C1A5Q38423384-ED74D12B-6758-462E-894A-271E19A4B872Q38569945-63A5A508-AA8B-4901-8955-B462A4869684Q38962044-986ED33E-A728-44E4-B214-BD091534B64DQ39114185-CACA0C8D-4B0E-4FEB-8145-28020C289CDFQ39174701-86F5A222-CE68-4EAB-9AF7-0F96E6204EECQ39340978-FBA81CCE-5A62-49C1-A53E-EDBA8E8BFAB6Q40078310-60552CCD-4F26-406F-8733-F9B739CF025AQ41195887-81DD7B32-0F8A-4E34-84A5-01ED14746A69Q41564669-12E76D11-867A-463E-A326-584C83619E6CQ42074184-6054F595-68CB-4777-B80B-5981CCF54B4DQ42702473-ED965244-B66F-4515-B6B0-8D7830FD3F12Q43089720-A43B211A-C030-4428-BBD1-CA85E8C43B22Q43136598-CBDF713D-184B-43E4-ACA6-19FE7BF1E891Q44987446-8768F187-3F26-43C3-B110-7A9A16EC8711Q50989206-79067DB1-4DD2-4552-B412-F10FC00BD3A6Q53831007-5DA95FD6-B180-4BCB-825B-0D994710C00FQ57064243-DECD4EE8-8CD3-4F93-9FAE-40C0159D6DD7Q59273452-136FB6BB-E2E8-44CE-A091-985598D9057E
P2860
Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C
description
article
@en
im März 2011 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2011
@uk
name
Enhanced expression of pro-inf ...... liver disease and hepatitis C
@en
Enhanced expression of pro-inf ...... liver disease and hepatitis C
@nl
type
label
Enhanced expression of pro-inf ...... liver disease and hepatitis C
@en
Enhanced expression of pro-inf ...... liver disease and hepatitis C
@nl
prefLabel
Enhanced expression of pro-inf ...... liver disease and hepatitis C
@en
Enhanced expression of pro-inf ...... liver disease and hepatitis C
@nl
P2093
P50
P356
P1433
P1476
Enhanced expression of pro-inf ...... liver disease and hepatitis C
@en
P2093
Carmelo García-Monzón
Javier Vargas-Castrillón
José Luis Olcoz
María E Miquilena-Colina
Tamara Lozano-Rodríguez
P304
P356
10.1042/CS20100387
P407
P50
P577
2011-03-01T00:00:00Z